Yuansheng Capital
VC Fund
Yuansheng Capital is a new venture firm established by former Tencent Holding Ltd. executive Peng Zhijian in 2015.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries Yuansheng Capital invests in
Stages Yuansheng Capital invests in
Countries Yuansheng Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Yin Jie
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 6 (30%)
- Biotechnology 5 (25%)
- Medical 4 (20%)
- Biopharma 3 (15%)
- Medical Device 3 (15%)
Stage
- Series A 5 (25%)
- Series C 5 (25%)
- Series B 4 (20%)
- Venture - Series Unknown 2 (10%)
- Seed 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Yin Jie
Medical Device Partner
|
Medical Device Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Mingche Technology
|
Mingche Technology is an innovative ophthalmic medical device company. | Series A / Aug 06, 2026 | |
|
Moffett AI
|
MoXin is an AI chip designer, providing terminal and cloud AI chip acceleration solutions. | $147.5M / Series C / May 28, 2026 | |
|
Hailai Technology
|
Hailai Biotech is a biotechnology business dedicated on the discovery and development of next-generation bispecific and multispecific antibody drugs. | $8.5M / Angel / Dec 24, 2025 | |
AusperBio
|
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases. | $50.3M / Series B / May 28, 2025 | |
Carrot
|
Carote is a well-known brand of home cookware that includes cooking pots, water utensils, and more. The company began by offering OEM services to worldwide companies. | $40M / Venture - Series Unknown / Sep 23, 2024 | |
Chromai
|
Chromai offers high-performance intelligent liquid chromatography and medical diagnostic solutions. The company insists on independent innovation and takes the revitalization of national industry as its own responsibility. | $14.2M / Jun 05, 2023 | |
|
Chromai
|
Chromai offers high-performance intelligent liquid chromatography and medical diagnostic solutions. The company insists on independent innovation and takes the revitalization of national industry as its own responsibility. | $14.1M / Series A / Jun 05, 2023 | |
Qcraft
|
Qcraft operates as a self-driving startup company. Qcraft develops AV simulation testing, which refers to a system solution that trains self-driving cars to deal with vast traffic scenarios, especially unusual cases, on a virtual road network. | Series B / Dec 02, 2022 | |
ZVISION
|
Zvision provides automotive-grade solid-state LiDAR solution for autonomous driving applications. The company's first-generation laser radar products use MEMS technology, and plan to achieve scale-up in the L3-class autonomous driving and unmanned logistics fields in the next five years, and layout the next generation optical-based phasedarray (OPA) through its integrated chip research and development capabilities. The technical laser radar is aimed at the L4/L5 level autopilot market after 5-10 years. | Series C / Nov 16, 2022 | |
Degron Therapeutics
|
Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment. | $22M / Series A / Jun 09, 2022 | |
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yuansheng Capital invest in?
Yuansheng Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series C stage. Most of the 20 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Yuansheng Capital?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Yuansheng Capital?
The team at Yuansheng Capital includes Yin Jie (Medical Device Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
